These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35143780)

  • 1. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019.
    GBD 2019 Diabetes Mortality Collaborators
    Lancet Diabetes Endocrinol; 2022 Mar; 10(3):177-192. PubMed ID: 35143780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Causes of Death Collaborators
    Lancet; 2017 Sep; 390(10100):1151-1210. PubMed ID: 28919116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Mortality Collaborators
    Lancet; 2017 Sep; 390(10100):1084-1150. PubMed ID: 28919115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Mortality and Causes of Death Collaborators
    Lancet; 2016 Oct; 388(10053):1459-1544. PubMed ID: 27733281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Diseases and Injuries Collaborators
    Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
    GBD 2016 Healthcare Access and Quality Collaborators
    Lancet; 2018 Jun; 391(10136):2236-2271. PubMed ID: 29893224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Benign Prostatic Hyperplasia Collaborators
    Lancet Healthy Longev; 2022 Nov; 3(11):e754-e776. PubMed ID: 36273485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.
    ;
    Lancet; 2017 Jul; 390(10091):231-266. PubMed ID: 28528753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 DALYs and HALE Collaborators
    Lancet; 2018 Nov; 392(10159):1859-1922. PubMed ID: 30415748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Epilepsy Collaborators
    Lancet Neurol; 2019 Apr; 18(4):357-375. PubMed ID: 30773428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Child Mortality Collaborators
    Lancet; 2016 Oct; 388(10053):1725-1774. PubMed ID: 27733285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Respiratory Tract Cancers Collaborators
    Lancet Respir Med; 2021 Sep; 9(9):1030-1049. PubMed ID: 34411511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Mortality Collaborators
    Lancet; 2018 Nov; 392(10159):1684-1735. PubMed ID: 30496102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Meningitis Collaborators
    Lancet Neurol; 2018 Dec; 17(12):1061-1082. PubMed ID: 30507391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Brain and Other CNS Cancer Collaborators
    Lancet Neurol; 2019 Apr; 18(4):376-393. PubMed ID: 30797715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
    GBD 2019 Healthcare Access and Quality Collaborators
    Lancet Glob Health; 2022 Dec; 10(12):e1715-e1743. PubMed ID: 36209761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.